Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents (ADAPT-DES)

This study has been completed.
Sponsor:
Collaborator:
Dickson Advanced Analytics Group
Information provided by (Responsible Party):
Cardiovascular Research Foundation, New York
ClinicalTrials.gov Identifier:
NCT00638794
First received: February 28, 2008
Last updated: January 22, 2013
Last verified: August 2012